Cost-Effectiveness Analysis of a Mobile-Based Intervention for Patients with Type 2 Diabetes Mellitus

Table 2

Correlation between HbA1c and cost (r).

	HbA1c	Total patient cost	Registration fee	Material fee	Treatment fee	Western medicine fee	Laboratory fee	Chinese patent drug fee
HbA1c
Total patient cost	0.202
Registration fee	0.062	0.797
Material fee	0.200	0.686	0.706
Treatment fee	−0.289	0.143	0.387	−0.068
Western medicine fee	0.172	0.887	0.909	0.773	0.207
Laboratory fee	−0.148	0.370	0.570	0.346	0.505	0.432
Chinese patent drug fee	0.101	0.587	0.530	0.575	−0.121	0.588	0.263
Hospitalization expenses	0.183	0.673	0.189	0.165	−0.057	0.265	−0.022	0.185

, .